These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21903764)

  • 1. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer.
    Appleyard CB; Cruz ML; Isidro AA; Arthur JC; Jobin C; De Simone C
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1004-13. PubMed ID: 21903764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.
    Uronis JM; Arthur JC; Keku T; Fodor A; Carroll IM; Cruz ML; Appleyard CB; Jobin C
    Inflamm Bowel Dis; 2011 Jan; 17(1):289-97. PubMed ID: 20564535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis.
    Isidro RA; Lopez A; Cruz ML; Gonzalez Torres MI; Chompre G; Isidro AA; Appleyard CB
    J Histochem Cytochem; 2017 Aug; 65(8):445-461. PubMed ID: 28692320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable response to probiotics in two models of experimental colitis in rats.
    Shibolet O; Karmeli F; Eliakim R; Swennen E; Brigidi P; Gionchetti P; Campieri M; Morgenstern S; Rachmilewitz D
    Inflamm Bowel Dis; 2002 Nov; 8(6):399-406. PubMed ID: 12454615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
    Pagán B; Isidro AA; Cruz ML; Ren Y; Coppola D; Wu J; Appleyard CB
    World J Gastroenterol; 2011 Nov; 17(44):4858-66. PubMed ID: 22171126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.
    Arthur JC; Gharaibeh RZ; Uronis JM; Perez-Chanona E; Sha W; Tomkovich S; Mühlbauer M; Fodor AA; Jobin C
    Sci Rep; 2013 Oct; 3():2868. PubMed ID: 24100376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.
    Soo I; Madsen KL; Tejpar Q; Sydora BC; Sherbaniuk R; Cinque B; Di Marzio L; Cifone MG; Desimone C; Fedorak RN
    Can J Gastroenterol; 2008 Mar; 22(3):237-42. PubMed ID: 18354751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.
    Nanda Kumar NS; Balamurugan R; Jayakanthan K; Pulimood A; Pugazhendhi S; Ramakrishna BS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1834-9. PubMed ID: 19120873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
    Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
    Amit-Romach E; Uni Z; Reifen R
    Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium.
    Osman N; Adawi D; Ahrne S; Jeppsson B; Molin G
    Dig Dis Sci; 2004 Feb; 49(2):320-7. PubMed ID: 15104378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition.
    Mar JS; Nagalingam NA; Song Y; Onizawa M; Lee JW; Lynch SV
    Gut Microbes; 2014 Jul; 5(4):494-503. PubMed ID: 25144681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
    Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistep mechanism of probiotic bacterium, the effect on innate immune system.
    Amit-Romach E; Uni Z; Reifen R
    Mol Nutr Food Res; 2010 Feb; 54(2):277-84. PubMed ID: 19998380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents.
    Ettreiki C; Gadonna-Widehem P; Mangin I; Coëffier M; Delayre-Orthez C; Anton PM
    World J Gastroenterol; 2012 Jun; 18(21):2619-29. PubMed ID: 22690070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.
    Schultz M; Munro K; Tannock GW; Melchner I; Göttl C; Schwietz H; Schölmerich J; Rath HC
    Clin Diagn Lab Immunol; 2004 May; 11(3):581-7. PubMed ID: 15138186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.